Difficulty: Medium
Average Score: 76%
Practice
Carbimazole differs from propylthiouracil in that:
Correct answer
C
Rationale
Correct Answer: C) Carbimazole does not produce an active metabolite.
Rationale:
1. Carbimazole is a prodrug that is converted to its active form, methimazole, in the body.
2. Methimazole is the active compound responsible for inhibiting thyroid hormone production.
3. Propylthiouracil, on the other hand, directly inhibits thyroid hormone synthesis without needing conversion.
4. Therefore, Carbimazole differs from propylthiouracil in that it requires metabolic activation to its active form, methimazole, and does not produce a different active metabolite like propylthiouracil does.
Summary:
A) Incorrect: Carbimazole is not dose to dose less potent compared to propylthiouracil; potency can vary based on individual response.
B) Incorrect: Carbimazole actually has a longer plasma half-life compared to propylthiouracil.
D) Incorrect: Carbim
Rationale:
1. Carbimazole is a prodrug that is converted to its active form, methimazole, in the body.
2. Methimazole is the active compound responsible for inhibiting thyroid hormone production.
3. Propylthiouracil, on the other hand, directly inhibits thyroid hormone synthesis without needing conversion.
4. Therefore, Carbimazole differs from propylthiouracil in that it requires metabolic activation to its active form, methimazole, and does not produce a different active metabolite like propylthiouracil does.
Summary:
A) Incorrect: Carbimazole is not dose to dose less potent compared to propylthiouracil; potency can vary based on individual response.
B) Incorrect: Carbimazole actually has a longer plasma half-life compared to propylthiouracil.
D) Incorrect: Carbim